BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 15564323)

  • 21. Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle.
    Sogos V; Balaci L; Ennas MG; Dell'era P; Presta M; Gremo F
    Dev Dyn; 1998 Apr; 211(4):362-73. PubMed ID: 9566955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
    Giri D; Ropiquet F; Ittmann M
    Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor-9 modulates the expression of myelin related proteins and multiple fibroblast growth factor receptors in developing oligodendrocytes.
    Cohen RI; Chandross KJ
    J Neurosci Res; 2000 Aug; 61(3):273-87. PubMed ID: 10900074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells.
    Kornmann M; Ishiwata T; Matsuda K; Lopez ME; Fukahi K; Asano G; Beger HG; Korc M
    Gastroenterology; 2002 Jul; 123(1):301-13. PubMed ID: 12105858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia.
    Thompson SD; Franklyn JA; Watkinson JC; Verhaeg JM; Sheppard MC; Eggo MC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1336-41. PubMed ID: 9543164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus-mediated transfer of a truncated fibroblast growth factor (FGF) type I receptor blocks FGF-2 signaling in multiple pancreatic cancer cell lines.
    Kleeff J; Kothari NH; Friess H; Fan H; Korc M
    Pancreas; 2004 Jan; 28(1):25-30. PubMed ID: 14707726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-tert-butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a selective tyrosine kinase inhibitor of fibroblast growth factor receptor-3 (FGFR3), inhibits cell proliferation of bladder cancer carrying the FGFR3 gene mutation along with up-regulation of p27/Kip1 and G1/G0 arrest.
    Miyake M; Ishii M; Koyama N; Kawashima K; Kodama T; Anai S; Fujimoto K; Hirao Y; Sugano K
    J Pharmacol Exp Ther; 2010 Mar; 332(3):795-802. PubMed ID: 19955487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting epidermal growth factor receptor 1 signaling in human thyroid-stimulating hormone-independent thyroid carcinoma FRO cells results in a more chemosensitive and less angiogenic phenotype.
    Landriscina M; Piscazzi A; Fabiano A; Maddalena F; Costantino E; Farese A; Bufo P; Cignarelli M
    Thyroid; 2009 Jun; 19(6):629-37. PubMed ID: 19499990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro.
    Künstlinger H; Fassunke J; Schildhaus HU; Brors B; Heydt C; Ihle MA; Mechtersheimer G; Wardelmann E; Büttner R; Merkelbach-Bruse S
    Oncotarget; 2015 Aug; 6(24):20215-30. PubMed ID: 26036639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis.
    Ye T; Wei X; Yin T; Xia Y; Li D; Shao B; Song X; He S; Luo M; Gao X; He Z; Luo C; Xiong Y; Wang N; Zeng J; Zhao L; Shen G; Xie Y; Yu L; Wei Y
    Breast Cancer Res Treat; 2014 Feb; 143(3):435-46. PubMed ID: 24398778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells.
    Bansal R; Magge S; Winkler S
    J Neurosci Res; 2003 Nov; 74(4):486-93. PubMed ID: 14598292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells.
    Byron SA; Loch DC; Pollock PM
    Int J Gynecol Cancer; 2012 Nov; 22(9):1517-26. PubMed ID: 23060048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.
    Sharpe R; Pearson A; Herrera-Abreu MT; Johnson D; Mackay A; Welti JC; Natrajan R; Reynolds AR; Reis-Filho JS; Ashworth A; Turner NC
    Clin Cancer Res; 2011 Aug; 17(16):5275-86. PubMed ID: 21712446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of FGF receptors by mutations in the transmembrane domain.
    Li Y; Mangasarian K; Mansukhani A; Basilico C
    Oncogene; 1997 Mar; 14(12):1397-406. PubMed ID: 9136983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of fibroblast growth factor 8 in human breast cancer.
    Marsh SK; Bansal GS; Zammit C; Barnard R; Coope R; Roberts-Clarke D; Gomm JJ; Coombes RC; Johnston CL
    Oncogene; 1999 Jan; 18(4):1053-60. PubMed ID: 10023681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications.
    Ezzat S; Zheng L; Winer D; Asa SL
    Mol Endocrinol; 2006 Nov; 20(11):2965-75. PubMed ID: 16857743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGFR signalling in women's cancers.
    Fearon AE; Gould CR; Grose RP
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.